Physician profile
Laura Stephens
NPI 1871002782
$1,253.27
in general payments reported to CMS, 2019-2025
22 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.62 · 2022: $23.98 · 2023: $35.87 · 2024: $112 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.68 |
| Education | $278.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $160.26 | 2023-2025 | |
| Revance Therapeutics, INC. | $125.00 | 2025 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $99.00 | 2024 | Sotyktu |
| Janssen Biotech, INC. | $94.99 | 2025 | Tremfya |
| Sanofi-Aventis U.S. LLC | $85.00 | 2025 | |
| Abbvie INC. | $79.89 | 2025 | |
| Incyte Corporation | $73.01 | 2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $67.84 | 2025 | Dupixent |
| Ucb, INC. | $63.38 | 2025 | Bimzelx |
| Organon LLC | $60.23 | 2025 | Vtama |
| Leo Pharma INC. | $56.13 | 2025 | Adbry, Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.92 | 2025 | Siliq, Cabtreo, Jublia |
| Genzyme Corporation | $38.69 | 2025 | |
| Lilly USA, LLC | $36.57 | 2025 | Ebglyss, Taltz |
| Arcutis Biotherapeutics, INC. | $33.37 | 2025 | Zoryve |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.19 | 2025 | |
| Qorumpartners | $23.98 | 2022 | |
| Sun Pharmaceutical Industries INC. | $22.42 | 2025 | |
| Coala Life INC | $19.91 | 2023 | Coala Heart Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $17.62 | 2021 | |
| Galderma Laboratories, L.P. | $16.48 | 2025 | Nemluvio |
| Glaxosmithkline, LLC. | $13.39 | 2024 | Rotarix, Bexsero, Pediarix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.